Randomized Control Trial To Study The Effect Of Coded Unani Formulation UNIM-904 And Amlodipine On Serum Lipid Profile And Electrolyte Level In Patients With Essential Hypertension.
DOI:
https://doi.org/10.37506/n1qb2r81Keywords:
Essential hypertension, blood pressure, precision medicine, Lipid profileAbstract
Abstract
Essential hypertension, is a major health problem in developed countries, affecting nearly one billion people worldwide [1]. It has a strong association with cardiovascular disease and contributes greatly to morbidity, mortality economic burden [2], Accounting for about 57% of all deaths due to stroke and 24% of all deaths due to coronary heart disease in India [3]. By 2025, the number of hypertensive individuals may rise to 213 million from 118 million in 2000 [4]. The major risk factors for hypertension include obesity, smoking, alcohol consumption, and dyslipidaemia apart from the dietary pattern [5]. Various studies have implicated a close association of dyslipidaemia and hypertension [6,7]. Herbal medicines origin has been extensively used in the therapeutic management of hypertension for a long time.
Aim of the study: To study the Effect of coded Unani formulation UNIM-904 on serum Lipid profile and electrolyte level with allopathic drug amlodipine before and after treatment in patients with essential Hypertension.
Materials and methods: The data presented in this work Randomized and open-level clinical trial conducted on 40 UNIM-904 and 40 amlodipine cases at the Regional Research Institute of Unani Medicine, Mumbai, from 2014-2018. The participants of any sex aged between 30 and 60 years. The participants of the treatment group were treated with coded Unani formulation UNIM-904 5 gm BD/day) and Amlodipine 5 mg OD/day) was given to the control group for 84 days once at night daily.
The statistical analysis of the presented data was done using a paired t-test and a p-value of ≤0.05 was considered significant). The study indicates that when results were compared with baseline to end of treatment of two groups treated with Unani and allopathic drugs, namely, UNIM-904 and amlodipine, the former showed a significant.
Results: We observed a significant reduction (treatment group versus control group) in mean serum potassium by 4.91 versus 4.45, Calcium 9.34 versus 8.52, Cholesterol 169.93 versus 198.87, HDL-Cholesterol 47.97 versus 44.29 levels was statistically significant after Treatment in both Groups. Thus, it is concluded that both the drugs do possess the anti-hypertensive activity and reduce systolic, and diastolic blood pressure respectively, there were no significant changes in liver function tests as well as kidney function tests. yet the Unani-coded drug has shown a comparatively better rate of safety and without side effects and, therefore, recommended for use in essential hypertension cases. Further studies are suggested on a larger group of essential hypertensive patients to develop safe, effective, viable, and cheap herbal drug to combat hypertension evading satisfactory cure in modern medicine.
References
References:
Kotchen TA. Hypertensive Vascular Disease. Harrison’s Principles of Internal Medicine. (18th Edition) Part 10(Section 5):2042–2052. Chapter 247 [Google Scholar]
Buttar HS, Li T, Nivedita R. Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol. 2005;10(4):229–49. [PMC free article] [PubMed] [Google Scholar]
Gupta R, Gupta N. Hypertension epidemiology in the 21st century. India J Preventive Cardiology. 2013;2(4):1–6. [Google Scholar]
Reddy KS, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet. 2005; 366:1744–49. [PubMed] [Google Scholar]
Bhavani BA, Padma T, Sastry BK, Krishna Reddy N. Plasma Lipoprotein (a) levels in patients with untreated essential hypertension. Indian J Hum Genet. 2003;9(2):65–68. [Google Scholar]
Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA. 1991; 265:2079–84. [PubMed] [Google Scholar]
Borghi C. Interactions between hypercholesterolemia and hypertension; implications for therapy. Current Opinion in Nephrology and Hypertension. 2002;11(5):489–96. [PubMed] [Google Scholar]
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224–2260.
Leeder S, Raymond S, Greenberg H, Liu H. A race against time. The challenge of cardiovascular disease in developing economies. New York: Columbia University; 2004.
Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 2005; 366:1744–1749.
Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens 2004; 18:73–78.
Mackay J, Mensah G. Atlas of heart disease and stroke. Geneva: World Health Organization; 2004.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367:1747–1757.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217–223.
Thankappan KR, Sivasankaran S, Sarma PS, Mini G, Khader SA, Padmanabhan P, et al. Prevalence-correlates-awareness-treatment and control of hypertension in Kumarakom, Kerala: baseline results of a community-based intervention program. Indian Heart J 2006; 58:28–33.
Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 2007;20(4):370-377.
Huang Z, Willett WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998;128(2):81-88.
Parker ED, Schmitz KH, Jacobs DR Jr, Dengel DR, Schreiner PJ, et al. Physical activity in young adults and incident hypertension over 15 years of follow-up: the CARDIA study. Am J Public Health 2007;97(4):703-709.
Pereira MA, Folsom AR, McGovern PG, Carpenter M, Arnett DK, Liao D, et al. Physical activity and incident hypertension in black and white adults: the atherosclerosis risk in communities study. Prev Med 1999;28(3):304-312.
Thadhani R, Camargo CA Jr, Stampfer MJ, Curhan GC, Willett WC, Eric BR. Prospective study of moderate alcohol consumption and risk of hypertension in young women. Arch Intern Med 2002;162(5):569-574.
Witteman JC, Willett WC, Stampfer MJ, Colditz GA, Kok FJ, Sacks FM, et al. Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol 1990;65(9):633-637.
Curhan GC, Willett WC, Rosner B, Stampfer MJ. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med 2002;162(19):2204- 2208.
Sever PS, Poulter NR. A hypothesis for the pathogenesis of essential hypertension: the initiating factors. J Hypertension 1989;7(s1):S9-S1.
Fisher NDL, Williams GH, Harrison’s principle of internal medicine, Vol. 2nd, 16 edition, Hypertensive vascular disease, McGraw-Hill, 1463-1480.
Arif M. Clinical study on primary hypertension and a comparative evaluation of Qurs-e-Dawa-us- Shifa with amlodipine in its management. Department of Moalejat, Aligarh Muslim University 2008, 35-52.
Nisar SS. Clinical study on essential hypertension and evaluation of the efficacy of persiyoshan and Sankhaholi in its management. Department of Moalejat, Jamia Hamdard, New Delhi 2012, 58-65.
Amraz-e- Qalbe, (CCRUM, New Delhi) 1995, 208-230.
Khan QA, Khan AA, Jabeen A, Jahangir U, Khalid M and Ansari S. Essential hypertension: a co relational approach in Unani medicine. Int J Pharmacognosy 2016;3(6):240-45.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Nirmala Devi MK, Mohd Adil, Nikhat Shaikh, Irfan Ahmad, Shah Alam, Piyush Yadav, Gazala Javed

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en